Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.650
-0.075 (-4.35%)
At close: Nov 20, 2024, 4:00 PM
1.550
-0.100 (-6.06%)
After-hours: Nov 20, 2024, 7:20 PM EST
Evogene Employees
Evogene had 142 employees as of December 31, 2023. The number of employees increased by 5 or 3.65% compared to the previous year.
Employees
142
Change (1Y)
5
Growth (1Y)
3.65%
Revenue / Employee
$66,542
Profits / Employee
-$139,908
Market Cap
9.21M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vincerx Pharma | 42 |
| Vaccinex | 40 |
| FOXO Technologies | 29 |
| Quantum BioPharma | 17 |
| SeaStar Medical Holding | 12 |
| COSCIENS Biopharma | 12 |
| BioRestorative Therapies | 11 |
EVGN News
- 1 day ago - Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - PRNewsWire
- 8 days ago - Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - PRNewsWire
- 13 days ago - Evogene Schedules Third Quarter 2024 Financial Results Release - PRNewsWire
- 20 days ago - Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - PRNewsWire
- 22 days ago - Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - PRNewsWire
- 6 weeks ago - Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PRNewsWire
- 7 weeks ago - Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - PRNewsWire
- 3 months ago - Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement - PRNewsWire